EDN1 and myeloid sarcoma: The likely source of this ET-1 production are reactive astrocytes in focal MS lesions, which express high levels of ET-1, while resting astrocytes in human brain visually do not show ET-1 immunoreactivity (D’Haeseleer et al., 2013).